Photoprotective and antioxidant effects of Rhubarb: inhibitory action on tyrosinase and tyrosine kinase activities and TNF-α, IL-1α and α-MSH production in human melanocytes by unknown
Silveira et al. BMC Complementary and Alternative Medicine 2013, 13:49
http://www.biomedcentral.com/1472-6882/13/49RESEARCH ARTICLE Open AccessPhotoprotective and antioxidant effects of
Rhubarb: inhibitory action on tyrosinase and
tyrosine kinase activities and TNF-α, IL-1α and
α-MSH production in human melanocytes
Jéssica PS Silveira1, Leonardo N Seito1, Samara Eberlin2, Gustavo C Dieamant2, Cecília Nogueira2,
Maria CV Pereda2 and Luiz C Di Stasi1*Abstract
Background: Exposure to ultraviolet (UV) radiation causes various forms of acute and chronic skin damage,
including immunosuppression, inflammation, premature aging and photodamage. Furthermore, it induces the
generation of reactive oxygen species, produces proinflammatory cytokines and melanocyte-stimulating hormone
(MSH) and increases tyrosinase activity. The aim of this study was to evaluate the potential photoprotective effects
of Rheum rhaponticum L. rhizome extract on human UV-stimulated melanocytes.
Methods: The effects of Rheum rhaponticum rhizome extract on tyrosine kinase activity, and on interleukin-
1α (IL-1α), tumour necrosis factor α (TNF-α), and α-MSH production in human epidermal melanocytes were evaluated
under UV-stimulated and non-stimulated conditions. Antioxidant activity was evaluated by lipid peroxidation and
1,1-dyphenyl-2-picryl-hydrazyl (DPPH) assays, while anti-tyrosinase activity was evaluated by the mushroom
tyrosinase method.
Results: Rheum rhaponticum L. rhizome extract showed in vitro antioxidant properties against lipid peroxidation,
free radical scavenging and anti-tyrosinase activities, and inhibited the production of IL-1α, TNF-α, α-MSH, and
tyrosine kinase activity in melanocytes subjected to UV radiation.
Conclusions: These results support the inclusion of Rheum rhaponticum L. rhizome extract into cosmetic,
sunscreen and skin care products for the prevention or reduction of photodamage.
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Exposure to UV solar radiation has deleterious effects on
human skin, inducing a number of skin disorders such
as immune suppression, inflammation, photo-aging, sun-
burn, dermatitis, solar urticaria and skin cancer [1]. For
protection against UV damage, human skin is equipped
with a complex defence system, including skin pigmen-
tation, skin thickening and a network of enzymatic and
non-enzymatic antioxidants [2-4]. Skin pigmentation is* Correspondence: ldistasi@ibb.unesp.br
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reproduction in any medium, provided the orone of the first events in response to UV radiation,
which increases proliferation, activity and dendricity of
melanocytes, followed by the synthesis and activation of
tyrosinase and finally by the transfer of melanosomes to
keratinocytes [2]. Melanocytes are key components of the
skin pigmentary system and a significant source of various
cytokines, including interleukin 1 α (IL-1α) and tumour
necrosis factor α (TNF-α), which are released by UVB-
exposed cells [2,5]. Skin pigmentation is also regulated by
the activation of tyrosinase, a rate-limiting enzyme
involved in the process of melanin synthesis (2). Interest-
ingly, melanocyte growth and melanogenesis are also
linked to the activation of tyrosine kinase activity and
tyrosine kinase receptors [6,7]. In addition, the UVLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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via the generation of reactive oxygen and nitrogen species
and is involved in the development of cutaneous inflam-
mation [2,5]. These reactive species exert deleterious
effects by oxidizing biologically essential molecules and
induced oxidative damage of cellular membranes, tissues,
and enzymes, which may lead to several diseases [4,8].
Oxidative stress is counteracted by the endogenous pro-
duction of enzymatic antioxidants such as superoxide
dismutase, glutathione peroxidase, and catalase and a
large concentration of non-enzymatic antioxidants,
mainly glutathione and exogenous components such as
carotenoids, flavonoids, and other phenolic compounds,
including vitamin E and vitamin C [1,3,9], which act by
several mechanisms in the maintenance of health and pre-
vention of several disorders and diseases [4,10]. On the
basis of these observations, modulation of the metabolism
of skin pigmentation by natural active compounds with
anti-tyrosinase and antioxidant properties has been used
as an innovative strategy to develop new products for
skin photoprotection [3,11-14]. Although isolated plant
compounds have a high potential in skin protection,
whole herbs extracts like black tea, aloe and sesame oil
showed better potential due to their chemical complex
composition [15].
Plants from the Polygonaceae family that are rich in anti-
tyrosinase and antioxidant stilbene compounds have been
used as a source of photoprotectants and skin-lightening
products [16-18]. These active stilbene compounds are
plant secondary metabolites structurally related to
resveratrol, a compound with well-documented potent
photoprotective, antioxidant and anti-tyrosinase proper-
ties [19,20]. Recently, we demonstrated that another medi-
cinal plant from the Polygonaceae family, Coccoloba
univefera, protects human melanocytes after exposure to
UV radiation [21]. On the basis of this evidence, Rheum
rhaponticum L., an Asian medicinal plant commonly
known as Rhubarb or Sibiric Rhubarb, was selected for
the present study. In addition to its widely known laxative
effect, this plant is also used to treat a broad spectrum of
disorders, including kidney stones, gout, and liver and in-
testinal diseases [22]. Externally, this plant is also used to
treat skin lesions such as sores and scabs [22]. In addition
to containing stimulant laxative anthraquinones and
astringents tannins, the rhizomes of Rheum rhaponticum
and other polygonaceous species contain antioxidant
and anti-tyrosinase hydroxystilbene compounds such
as piecetannol, rhaponticin and desoxyrhaponticin [16-18].
Therefore, the aim of this study was to investigate the
in vitro antioxidant and anti-tyrosinase activities of
Rheum rhaponticum L. rhizome extract and its effect on
the production of IL-1bα, TNF-α, α-MSH and tyrosine
kinase activity in human melanocytes with or without
exposure to UV radiation.Methods
Plant material
Rheum rhaponticum L. dry rhizomes were obtained dir-
ectly from Quimer Industries Ltd, São Paulo, Brazil. The
voucher specimens are available within the supplier
company where plant authentication was performed by
botanists. Dry rhizomes were used to obtain a methanol
extract, which was concentrated in a rotary evaporator.
Plant extract was dissolved in an aqueous solution of
20% DMSO for antioxidant and anti-tyrosinase activities
or in culture medium for studies on the irradiated and
non-irradiated melanocyte cultures.
Antioxidant and anti-tyrosinase activities
Two in vitro assays were used to test the antioxidant ac-
tivity of the Rheum rhaponticum rhizome extract: the
lipid peroxidation assay in rat brain membranes [23]
modified from the original protocol [24] and the DPPH
assay [25]. The plant concentration used for these assays
ranged of 6 to 400 mg/ml. Quercetin, a potent antioxi-
dant compound, was used as a reference drug. This ex-
perimental protocol met the “Guidelines of Animal
Experimentation” and was approved by the Commission of
Ethics in Animal Research (Protocol number 042/04-CEEA),
Institute of Biosciences, Univ. Estadual Paulista, UNESP.
For anti-tyrosinase activity, enzymatic assay with mush-
room tyrosinase [26] was used to evaluate tyrosinase in-
hibitory activity of the test compounds dissolved in 20%
DMSO (50–3200 mg/ml). Kojic acid, a potent anti-
tyrosinase agent, was used as a reference drug.
For both studies, each experiment was conducted in
triplicate of six independent experiments.
Cell culture and cell viability
Human epidermal melanocytes (Cryopreserved HEM,
Cat. 104-05n) were subcultured in 25 cm2 flasks
(Corning Inc, New York, NY) at 37°C in a 5% CO2 hu-
midified incubator and expanded for at least five
passages. After obtainment of the 80-90% confluence,
cells were trypsinised and seeded using 24-well culture
plates. After 24 hours, cells were washed with PBS,
irradiated with different doses of ultraviolet radiation
(75, 150, 300, 600 and 1200 mJ/cm2) and incubated with
various doses (0.6 to 153.6 mg/mL) of plant extract.
Cell-free supernatants and cell lysate were collected after
48 h of treatment, and assays were performed using
commercial kits and conducted in triplicate of three in-
dependent experiments.
Cell viability was measured using the 3-(4,5-
dimethylthi-azol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT, Sigma) assay as described previously [27]. Mel-
anocyte viability was evaluated after treatment with vari-
ous plant extract concentrations and various UV doses.
For UV irradiation was used a multiport solar UVA and
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PA) equipped with a 150 W Xenon lamp, with two
filters (a liquid and 1-mm Schott WG 320 filters) emit-
ting a continuous spectrum of radiation beginning at
290 nm through the infrared spectrum and peaking at
400 nm. After this study the concentrations of 0.6, 1.2,
2.4 and 4.8 mg/ml and UV dose of 300 mJ/cm2 were
selected because no loss of melanocyte viability was
observed with these treatments.
Quantification of biochemical mediators
The quantification of α-MSH was evaluated according
methodology described in a commercial enzymatic im-
munoassay kit (Phoenix Pharmaceuticals Inc., Belmont,
CA). α-MSH titres were expressed as ng/ml and were
calculated by referring to standard curves constructed
with known amounts of recombinant peptides.
The quantification of the IL-1α and TNF-α were were
evaluated according methodology described in a com-
mercial ELISA kit (DuoSet, R&D Systems, Minneapolis,
MN). Cytokine titres were expressed as pg/ml and were
calculated by referring to standard curves constructed
with known amounts of recombinant cytokines.
An immunoprecipitation assay kit (US Biological,
Swampscott, MA) was used to determine the tyrosine kin-
ase activity. The observed tyrosine kinase activity was
compared with known standards and expressed as pg/ml.
For all biochemical determinations, optical density was
read using a microplate reader at 450 nm.
Statistical analysis
For statistical analysis, one-way analysis of variance
followed by the Tukey test was used to compare the dataFigure 1 Effects of Rheum rhaponticum L. extract (RRE) and kojic acid
production by human melanocytes exposed and unexposed to ultrav
individual experiments, performed in triplicate. *P < 0.001 compared with c
exposed to UV radiation.among all groups. Statistical significance was considered
when P < 0.05.Results
Antioxidant and antityrosinase activities
The effect of Rheum rhaponticum rhizome extract on
the lipid peroxidation in rat brain membranes was
compared with the effect of quercetin, a well-known fla-
vonoid with potent antioxidant activity. The IC50 value
of the extract was 8.92 ± 1.21 μg/ml, whereas the IC50 of
quercetin was 0.53 ± 0.03 μg/ml. The EC50 scavenging
activity of Rheum rhaponticum rhizome extract against
DPPH radicals was 32.4 ± 4.37 μg/ml, whereas the EC50
of quercetin was 2.23 ± 0.82 μg/ml. The inhibitory effects
of Rheum rhaponticum rhizome extract on tyrosinase
activity were compared with those of kojic acid. The
IC50 of the extract was 0.06 ± 0.01 μg/ml, and the IC50 of
kojic acid was 0.02 ± 0.008 μg/ml.Rheum rhaponticum rhizome extract reduces α-MSH
production in melanocytes
α-MSH levels were assessed following exposure to
Rheum rhaponticum rhizome extract. Reduced α-MSH
release was elicited by the two highest doses (2.4 and
4.8 mg/ml) of Rheum rhaponticum rhizome extract
(Figure 1). The treatment of melanocytes with UV
radiation resulted in a 3.5-fold increase in α-MSH levels
compared with non-irradiated melanocytes. Considering
the groups that were exposed to UV radiation, a
decrease in α-MSH levels was observed at all tested
doses. These effects were similar to those produced by
kojic acid.(KA) on alpha-melanocyte stimulating hormone (α-MSH)
iolet radiation. Data are presented as the mean ± S.E.M. of six
ontrol unexposed to UV radiation; +P < 0.001 compared with control
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1α level in melanocytes
IL-1α production was assayed in human melanocyte
cultures that were and were not exposed to UV radiation
(Figure 2). In the first set of experiments performed on
melanocytes under basal conditions, Rheum rhaponticum
rhizome extract decreased IL-1α levels at all tested doses
compared with controls. This effect was similar to those
produced by the reference compound, kojic acid. Treat-
ment of melanocytes with UV radiation resulted in a 1.52-
fold increase in IL-1α levels compared with controls. This
increase was prevented similarly by both the plant extract
and kojic acid.
Rheum rhaponticum rhizome extract decreases the
TNF-α level in melanocytes
The effects of Rheum rhaponticum rhizome extract on the
TNF-α levels in melanocyte cultures were also evaluated
under basal and irradiated conditions (Figure 3). TNF-α
levels in melanocytes were not altered by the plant extract
under basal conditions. Treatment of cells with UV radi-
ation significantly increased TNF-α, which was prevented
by the treatment of melanocytes with RRE. This inhibitory
effect was similar to the inhibitory effect produced by the
reference compound.
Inhibitory effect of the Rheum rhaponticum rhizome
extract on tyrosine kinase activity in melanocytes
Rheum rhaponticum rhizomes extract reduced tyrosine
kinase activity in melanocyte cultures under basal
conditions. As we expected, UV radiation produced a
sharp 1.64-fold increase in enzymatic activity, which was
also prevented by the treatment of cells with allFigure 2 Effects of Rheum rhaponticum L. extract (RRE) and kojic acid
exposed and unexposed to ultraviolet radiation. The data are presente
triplicate. *P < 0.001 compared with control unexposed to UV radiation; +Pconcentrations of plant extract (Figure 4). This preventa-
tive effect was similar to that produced by the reference
compound.
Discussion
Natural compounds that originate from plants and plant
extracts and are able to inhibit tyrosinase activity have
been used as cosmetic additives and medicinal bioactive
substances in skin-lightening and photoprotective products
[2,11-15,28]. These natural products exhibit a range of im-
portant pharmacological activities to control hyperpigmen-
tation and to produce UV skin protection acting as
antioxidant, immune-modulatory and anti-inflammatory
activities [2,9,14,29]. The skin pigmentation and tanning
response to UV radiation is one of the most common
examples of environmental adaptations in humans [30].
Pigmentary effects of UV radiation are mediated by pro-
opiomelanocortin peptides (POMC), particularly α-MSH,
which is produced by melanocytes and keratinocytes to
regulate melanocytes and skin pigmentation [31-34]. It has
been demonstrated that UV radiation increases the expres-
sion of the melanocortin-1 receptor which, after α-MSH
agonist action, promotes a darkening effect [34,35]. In
addition, α-MSH stimulates human melanocyte growth by
binding to high-affinity receptors, particularly those related
to tyrosine kinase [7]. Tyrosine kinase activation is also
related to melanogenesis, and it has been demonstrated
that responses produced by its activation were attenuated
by tyrosine kinase inhibitors [36]. In our study, the data
clearly showed that Rheum rhaponticum rhizome extract
inhibits UV-induced α-MSH production in melanocytes.
This inhibition also occurred under basal conditions and
was similar to the pure reference compound, kojic acid,(KA) on interleukin-1 (IL-1) production by human melanocytes
d as the mean ± S.E.M. of six individual experiments, performed in
< 0.001 compared with control exposed to ultraviolet radiation.
Figure 3 Effects of Rheum rhaponticum L. extract (RRE) and kojic acid (KA) on tumour necrosis factor α (TNF-α) production by human
melanocytes exposed and unexposed to ultraviolet radiation. Data are presented as the mean ± S.E.M. of six individual experiments,
performed in triplicate. *P < 0.001 compared with control unexposed to UV radiation; +P < 0.01 compared with control exposed to UV radiation.
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rhaponticum rhizome extract also inhibited tyrosine activ-
ity in human melanocytes under basal conditions and after
UV stimulation. With the exception of Coccoloba uvifera,
inhibitory effects on melanocyte α-MSH production have
not been demonstrated for other polygonaceous plants or
stilbene compounds [20,21,37]. However, medicinal plants
from other botanical families have been shown to inhibit
melanin biosynthesis via inhibition of α-MSH production
in melanocytes [38-40].
Although the action of α-MSH is a key factor for skin
pigmentation, studies have demonstrated that α-MSHFigure 4 Effects of Rheum rhaponticum L. extract (RRE) and kojic acid
and unexposed to ultraviolet radiation. Data are presented as the mean
compared with control unexposed to UV radiation; + P < 0.001 compared witalso exhibits actions unrelated to pigmentation, such as
secreting a range of molecules involved in skin homeo-
stasis [34]. In fact, melanocytes have a complex network
of functions and mediators; they can act as local stress
sensors in the epidermis, as neuroendocrine cells, and as
regulators of skin immune responses by producing several
cytokines and other factors, including IL-1, TNF-α, IL-6,
IL-3 and nitric oxide [34,41]. Interestingly, α-MSH also
has potent anti-inflammatory and immune-modulatory
activities because this peptide can antagonise the actions
of pro-inflammatory cytokines and peroxide-generated oxi-
dative stress [33,42]. In our study, the production of bothAKcp on tyrosine kinase activity in human melanocytes exposed
± S.E.M. of six individual experiments, performed in triplicate. *P < 0.001
h control exposed to UV radiation.
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was increased compared with control cells. After incuba-
tion with all tested doses of plant extract, IL-1α and
TNF-α production was significantly reduced. In addition,
Rheum rhaponticum rhizome extract also reduced IL-1α and
TNF-α production in non-irradiated human melanocytes.
The effects of α-MSH on melanogenesis are also
mediated by tyrosinase, the rate-limiting enzyme in the
process of melanin synthesis, which catalyses the neces-
sary conversion of L-tyrosine to dopaquinone for the
synthesis of both phaeomelanin and eumelanin. Thus,
tyrosinase inhibitors are recognised as therapeutic products
to treat local hyperpigmentation diseases and can be used
as skin-lightening agents, such as resveratrol, kojic and el-
lagic acids, hydroquinone and arbutin [13,28]. In the
present study, Rheum rhaponticum showed a potent anti-
tyrosinase activity in the mushroom tyrosinase assay, simi-
lar to that produced by pure kojic acid. Although various
natural compounds and plant extracts have been studied
with the mushroom tyrosinase assay, Rheum rhaponticum
rhizome extract inhibited activity by 50% at one of the
lowest active doses that was tested compared with other
natural products and plant extracts, including Coccoloba
uvifera [11,21,25,43,44].
In addition to skin pigmentation, the decrease in react-
ive oxygen species generation has been shown to be im-
portant in other pathways involved in the prevention of
UV-induced skin disorders [2,3]. Chronic exposure of
skin to UV radiation results in an excessive production
of reactive oxygen species, promoting oxidative stress
and several skin-related disorders [45-47]. In fact, natural
and synthetic antioxidant products have been studied as
skin photoprotectants and skin-lightening agents, includ-
ing polyphenols (flavonoids, coumarins, anthocyanins,
catechins, tannins and stilbenes), alkaloids, isothiocyanates,
carotenoids and vitamins [3,9,28,48,49]. Stilbene antioxi-
dant compounds from the Polygonaceae family, including
the Rheum species, have been linked to the prevention of
skin photodamage [19,20,29,49]. These data are similar to
those observed in our study, where the protective effects of
Rheum rhaponticum rhizome extract was also linked to
their antioxidant and radical scavenging properties, as
evaluated by lipid peroxidation of brain membranes and
DPPH assays, respectively. In addition, antioxidant capacity
against lipid peroxidation and free radical scavenging cap-
acity in vitro has been described as important assays to de-
termine antioxidant properties of different compounds
potentially useful to prevent a disease [10].
Conclusion
Our short-term study provides the first evidence that
Rheum rhaponticum rhizome extract can modulate dam-
age induced by UV radiation. Because the skin response
to UV radiation is a complex process, it might be arguedthat agents that contribute to re-establishing normal
skin conditions should consist of as many mediators as
possible. Rheum rhaponticum extract acts through mul-
tiple mechanisms, including antioxidant and radical
scavenging properties, inhibition of tyrosinase and tyrosine
kinase activities, and IL-1α, TNF-α and α-MSH production
in human melanocytes subjected to UV stimulation. These
results support the inclusion of this extract in skin-
lightening products, as well as in cosmetic, sunscreen and
skin care products for the prevention or reduction of
photodamage. Clinical studies are necessary to support
these claims, as is further elucidation of the pharmaco-
logical mechanisms involved.
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